Recurrent Osteosarcoma Completed Phase 2 Trials for Ixabepilone (DB04845)

Also known as: Osteosarcoma recurrent / Osteogenic sarcoma recurrent

IndicationStatusPhase
DBCOND0028757 (Recurrent Osteosarcoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00331643Ixabepilone in Treating Young Patients With Refractory Solid TumorsTreatment